Search Results 461-470 of 12906 for immunosuppressant drugs

  1. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments - Mayo Clinic News Network

    ... immunosuppression or having another high-risk condition, the potential benefit of QTc-prolonging medicines may exceed the arrhythmia risk. "Importantly, the ...

  2. Immune globulin-stwk (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. Ublituximab-xiiy (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Bupivacaine liposome (injection route) - Side effects & uses - Mayo Clinic

    Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the ...

  5. Sibeprenlimab-szsi (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Do Patients Know They're Taking Off-Label Drugs? - Mayo Clinic News Network

    ... medicine, off-label drug use has become very common. Health care providers and patients should educate themselves about off-label drugs in order to weigh ...

  7. Non Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  8. Elvitegravir, cobicistat, emtricitabine, and tenofovir (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is usually given to adult patients who have yet not received any medicine for HIV infection. Elvitegravir, cobicistat, emtricitabine, and ...

  9. Transforming the future of organ transplantation - Mayo Clinic News Network

    Mayo Clinic is turning to regenerative medicine to address a critical shortage of donor organs. ... Eliminating the need for lifelong immunosuppressant measures ...

  10. Doxorubicin liposome (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...